SCHEMBL11303497

SCHEMBL11303497

O=C1CC(N(c2ccc(Cl)cc2)c2ccc(C(=O)NO)cc2)CN1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 8/20 0.46
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HDAC1 Q13547 9/20 0.39
▸ HDAC6 Q9UBN7 7/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ FPR1 P21462 1/20 0.38
▸ FPR2 P25090 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ ADAM17 P78536 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ FLT1 P17948 1/20 0.37
▸ FLT4 P35916 1/20 0.37
▸ KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297190 0.89 HDAC6 (0.44) HDAC8HDAC1HDAC6HDAC2KDM4E
SCHEMBL11303321 0.89 HDAC8 (0.44) HDAC8HDAC1HDAC6HDAC2
SCHEMBL11300774 0.88 HDAC6 (0.41) HDAC8HDAC1HDAC6KDM4EMEN1
SCHEMBL11297461 0.85 HDAC8 (0.37) HDAC8HDAC1HDAC6HDAC2KDM4E
SCHEMBL11296626 0.79 HDAC8 (0.49) HDAC8ALDH1A1HDAC1KDM4E
SCHEMBL11300763 0.79 HDAC8 (0.42) HDAC8KDM4EMEN1LMNAALOX15
SCHEMBL11301806 0.76 ALDH1A1 (0.41) HDAC8ALDH1A1POLBTDP1HDAC1
SCHEMBL11301804 0.76 ALDH1A1 (0.41) HDAC8ALDH1A1POLBTDP1HDAC1
SCHEMBL11298688 0.76 HDAC8 (0.42) HDAC8ALDH1A1POLBTDP1HDAC1
SCHEMBL11301754 0.75 PSEN1 (0.42) HDAC8ALDH1A1POLBTDP1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback